Press Releases
New number of shares and votes in Ambea AB ( publ )
October 30, 2026
Ambea AB ( publ ) (”Ambea”) today announces that the number of shares and votes in Ambea has changed as a result of new share issues carried out in connection with Ambea’s public takeover offer to the shareholders in Humana AB (“Humana”).
Ambea’s Nomination Committee appointed for the Annual General Meeting 2027
October 23, 2026
The Nomination Committee ahead of the AGM 2027 consists of:
Invitation: Presentation of Ambea’s interim report for the third quarter 2026
October 21, 2026
Ambea AB (publ) announces final outcome of the recommended public offer to the shareholders of Humana AB
October 15, 2026
Ambea and AGE-WELL partner to advance innovation and technology in senior care
October 7, 2026
Ambea, a leading Nordic care provider, and AGE-WELL, Canada’s technology and aging network, have formed a strategic partnership to accelerate the development and adoption of innovative care solutions. By combining Canadian research and technology expertise with Nordic care experience, the partnership aims to improve quality of life for older adults and provide better support for care professionals.
AMBEA AB ( PUBL ) COMPLETES THE RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF HUMANA AB AND EXTENDS THE ACCEPTANCE PERIOD
October 1, 2026
On 29 June 2026, Ambea AB ( publ ), registration number 556468–4354 (”Ambea”), announced a recommended public offer to the shareholders of Humana AB, registration number 556760–8475 (“Humana”) to tender all their shares in Humana to Ambea, aiming to combine the companies (the “Offer”). Ambea offers, for each share in Humana, SEK 20 in cash (the “Cash Consideration”), 0.305 shares in Ambea (the “Share Consideration”) and one (1) CVR Instrument entitling the holder to a potential future additional consideration (together with the Cash Consideration and the Share Consideration, the “Consideration”). The shares in Humana and Ambea, respectively, are admitted to trading on Nasdaq Stockholm. The offer document (the “Offer Document”) and the prospectus (the “Prospectus”) regarding the Offer were published on 24 August 2026. On 28 September 2026, Ambea announced that all approvals required for Ambea’s acquisition of Humana have been obtained.
AMBEA AB ( PUBL ) HAS OBTAINED ALL NECESSARY APPROVALS FROM AUTHORITIES REGARDING THE ACQUISITION OF HUMANA AB
September 28, 2026
On 29 June 2026, Ambea AB ( publ ), registration number 556468-4354 (“Ambea”), announced on a recommended public offer to the shareholders of Humana AB, registration number 556760-8475 (“Humana”) to tender all their shares in Humana to Ambea, aiming to combine the companies (the “Offer”).
AMBEA AB (PUBL) HAS COMPLETED THE SHARE REPURCHASE PROGRAM IN CONNECTION WITH THE RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF HUMANA AB
September 8, 2026
The Board of Directors of Ambea AB (publ) (“Ambea”) announces that the share repurchase program announced on 29 June 2026 has now been completed.
AMBEA AB ( PUBL ) PUBLISHES THE OFFER DOCUMENT AND THE PROSPECTUS REGARDING THE RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF HUMANA AB
August 24, 2026
This press release does not constitute an offer, either directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa, or in any other jurisdiction where an offer would be prohibited under the laws and regulations of such relevant jurisdiction. Shareholders who are not resident in Sweden and who wish to accept the Offer (as defined below) must carry out further enquiries regarding applicable legislation and possible tax consequences. Shareholders are referred to the offer restrictions set out in the section “Important Information” at the end of this press release and in the offer document. Shareholders in the US are also referred to the section “Important information for shareholders in the US” at the end of this press release.
Strong commitment to Nordic care
August 19, 2026
Ambea reports a strong second quarter of 2026, with continued growth, improved profitability, and strong cash generation. Earnings were driven by factors including higher occupancy, operational improvements, and continued expansion in the Nordic region. During the quarter, Ambea also announced a recommended public offer to acquire the care company Humana, with the aim of creating an even stronger Nordic care provider.
Invitation: Presentation of Ambea’s second quarter 2026 results
August 5, 2026
AMBEA AB ( PUBL ) RESOLVES ON REPURCHASE OF OWN SHARES IN CONNECTION WITH THE RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF HUMANA AB
June 29, 2026
Invitation: Presentation regarding Ambea's public offer to the shareholders of Humana
June 29, 2026
This press release does not constitute an offer, either directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa, or in any other jurisdiction where an offer would be prohibited under the laws and regulations of such relevant jurisdiction. Shareholders who are not resident in Sweden and who wish to accept the Offer (as defined below) must carry out further enquiries regarding applicable legislation and possible tax consequences. Shareholders are referred to the offer restrictions set out in the section “Important Information” at the end of this press release and in the offer document which will be published shortly before the start of the acceptance period for the Offer. Shareholders in the US are also referred to the section “Important information for shareholders in the US” at the end of this press release.
AMBEA AB ( PUBL ) ANNOUNCES A RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF HUMANA AB TO TENDER ALL THEIR SHARES IN HUMANA AB, AIMING TO COMBINE THE COMPANIES
June 29, 2026
This press release does not constitute an offer, either directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa, or in any other jurisdiction where an offer would be prohibited under the laws and regulations of such relevant jurisdiction. Shareholders who are not resident in Sweden and who wish to accept the Offer (as defined below) must carry out further enquiries regarding applicable legislation and possible tax consequences. Shareholders are referred to the offer restrictions set out in the section “Important Information” at the end of this press release and in the offer document which will be published shortly before the start of the acceptance period for the Offer. Shareholders in the US are also referred to the section “Important information for shareholders in the US” at the end of this press release.
Ambea signs agreement for new care home in Denmark
June 15, 2026
Ambea has, through its Danish company Altiden, entered into an agreement to establish a new care home in Nivå in Fredensborg Municipality, Denmark. The facility will comprise 88 places and is expected to be ready for occupancy in 2028.
Ambea strengthens its offering within child and youth care through an acquisition in Finland
June 1, 2026
Ambea has, through its Finnish business area Validia, signed an agreement to acquire the business operations of Ehot Ltd. The acquisition covers child and youth care services in Finland, focusing on foster care services and residential units.
New number of shares and votes in Ambea AB (publ)
May 29, 2026
Ambea AB (publ) (“Ambea”) today announces that the number of Ambea shares and votes has changed following (i) senior executives’ and key employees’ exercise of warrants in the incentive program 2023/2026, and (ii) the cancellation of 4,000,000 shares resolved upon by the Annual General Meeting 2026.
Report from Ambea´s Annual General Meeting 12 May 2026
May 12, 2026
Ambea signs agreement for new care home in Denmark
May 7, 2026
Ambea´s interim report January - March 2026
May 7, 2026
